R. Nichole Sumner
Known title: VP & ControllerCIK: 0001607503
Associated companies
Transaction History
| OLN | ▲ Buy | Option Exercise | 1,835 | — | 2/20/2026 | View on chart |
| OLN | ▼ Sell | Tax Withholding | 538 | $13K | 2/20/2026 | View on chart |
| OLN | ▲ Buy | Grant | 79 | $0 | 2/18/2026 | View on chart |
| OLN | ▲ Buy | Option Exercise | 4,750 | $62K | 2/3/2026 | View on chart |
| OLN | ▼ Sell | Open Market | 4,750 | $107K | 2/3/2026 | View on chart |
| OLN | ▲ Buy | Grant | 715 | $0 | 2/19/2025 | View on chart |
| OLN | ▲ Buy | Option Exercise | 10,500 | $288K | 11/8/2024 | View on chart |
| OLN | ▼ Sell | Open Market | 10,500 | $459K | 11/8/2024 | View on chart |
| OLN | ▲ Buy | Grant | 4,263 | $0 | 2/21/2024 | View on chart |
| OLN | ▲ Buy | Grant | 7,139 | $0 | 2/22/2023 | View on chart |
| OLN | ▲ Buy | Option Exercise | 550 | — | 1/2/2023 | View on chart |
| OLN | ▼ Sell | Tax Withholding | 191 | $10K | 1/2/2023 | View on chart |
| OLN | ▲ Buy | Option Exercise | 9,518 | $125K | 5/27/2022 | View on chart |
| OLN | ▼ Sell | Open Market | 9,518 | $617K | 5/27/2022 | View on chart |
| OLN | ▲ Buy | Option Exercise | 1,482 | $19K | 5/26/2022 | View on chart |
| OLN | ▼ Sell | Open Market | 1,482 | $96K | 5/26/2022 | View on chart |
| OLN | ▲ Buy | Grant | 3,618 | $0 | 2/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
UBS Cuts Olin Target to $18, Awaits Q3 Earnings
UBS has lowered its price target for Olin to $18 while maintaining a Neutral rating. This move comes just ahead of the company's Third Quarter 2026 earnings conference call. The stock is currently trading near its 52-week low, with an average analyst target of $20.20.
UBS Cuts Olin Target to $18, Awaits Q3 Earnings. UBS has lowered its price target for Olin to $18 while maintaining a Neutral rating. This move comes just ahead of the company's Third Quarter 2026 earnings conference call. The stock is currently trading near its 52-week low, with an average analyst target of $20.20.